Novanta (NOVT) CEO disposes 6,500 shares via Rule 10b5-1 plan

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Novanta Inc. Chief Executive Officer Matthijs Glastra reported selling a total of 6,500 shares of Novanta common stock on February 2, 2026. The sales were executed in several trades at weighted-average prices between $134.52 and $137.38 per share.

The transactions were made under a pre-established Rule 10b5-1 trading plan adopted on September 11, 2025 through a trust for which the reporting person’s spouse is a trustee. Following these sales, Glastra directly held 64,867 shares and indirectly held 54,382 shares through the Matthijs Glastra 2021 Irrevocable Trust.

Insider Trade Summary

Net Seller: 6,500 shares ($878,459)

Net Sell 5 txns

Insider Glastra Matthijs

Role Chief Executive Officer

Sold 6,500 shs ($878K)

Type	Security	Shares	Price	Value
Sale	Common Stock	3,606	$134.52	$485K
Sale	Common Stock	1,738	$135.50	$235K
Sale	Common Stock	1,108	$136.54	$151K
Sale	Common Stock	48	$137.38	$7K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 67,761 shares (Direct); Common Stock — 54,382 shares (Indirect, Matthijs Glastra 2021 Irrevocable Trust)

Footnotes (1)

The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee. This transaction was executed in multiple trades ranging from $133.96 to $134.95. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades ranging from $134.98 to $135.93. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades ranging from $136.02 to $136.92. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades ranging from $137.29 to $137.45. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Form 4 Insider Transactions: What Each Field Means →

02/04/2026 - 04:14 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Glastra Matthijs

(Last)

(First)

(Middle)

C/O NOVANTA INC.

125 MIDDLESEX TURNPIKE

(Street)

BEDFORD

01730

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
NOVANTA INC [ NOVT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/02/2026		S⁽¹⁾		3,606	D	$134.52⁽²⁾	67,761	D
Common Stock	02/02/2026		S⁽¹⁾		1,738	D	$135.5⁽³⁾	66,023	D
Common Stock	02/02/2026		S⁽¹⁾		1,108	D	$136.54⁽⁴⁾	64,915	D
Common Stock	02/02/2026		S⁽¹⁾		48	D	$137.38⁽⁵⁾	64,867	D
Common Stock								54,382	I	Matthijs Glastra 2021 Irrevocable Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person's spouse is a trustee.

2. This transaction was executed in multiple trades ranging from $133.96 to $134.95. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

3. This transaction was executed in multiple trades ranging from $134.98 to $135.93. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

4. This transaction was executed in multiple trades ranging from $136.02 to $136.92. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

5. This transaction was executed in multiple trades ranging from $137.29 to $137.45. The price reported above reflects the weighted-average price. The reporting person hereby undertakes to provide upon request from the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

Power of Attorney on file

	/s/ John Burke, Attorney-in-Fact	02/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Novanta (NOVT) report for its CEO?

Novanta reported that CEO and director Matthijs Glastra sold 6,500 shares of common stock on February 2, 2026. The sales occurred in multiple trades at weighted-average prices between $134.52 and $137.38 per share, as disclosed in the Form 4 filing.

At what prices did the Novanta (NOVT) CEO sell his shares?

The CEO’s sales were executed at weighted-average prices of $134.52, $135.50, $136.54, and $137.38 per share. Each price reflects multiple trades within narrow ranges, with full trade details available upon request to the company, regulators, or shareholders.

How many Novanta (NOVT) shares does the CEO hold after these sales?

After the reported sales, CEO Matthijs Glastra directly held 64,867 Novanta common shares. In addition, 54,382 shares were held indirectly through the Matthijs Glastra 2021 Irrevocable Trust, as shown in the Form 4 holding information.

Was the Novanta (NOVT) CEO sale part of a trading plan?

Yes. The Form 4 states the sales were effected under a pre-established Rule 10b5-1 trading plan. That plan was adopted on September 11, 2025 through a trust for which the reporting person’s spouse serves as a trustee.

What role does the trust play in the Novanta (NOVT) CEO’s holdings?

The filing shows 54,382 Novanta shares held indirectly through the Matthijs Glastra 2021 Irrevocable Trust. The sales were executed via a Rule 10b5-1 plan adopted through a trust where the CEO’s spouse is a trustee, as disclosed in the footnotes.

What is the position of the insider involved in this Novanta (NOVT) Form 4?

The reporting person, Matthijs Glastra, is both a director and the Chief Executive Officer of Novanta Inc. He is not listed as a 10% owner in the filing, but reports direct and indirect beneficial ownership of Novanta common stock.